Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients-Reference-Cited by-同舟云学术

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients

Published:2014-04-15 Issue:12 Volume:28 Page:2344-2354
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sakurai M,Kunimoto H,Watanabe N,Fukuchi Y,Yuasa S,Yamazaki S,Nishimura T,Sadahira K,Fukuda K,Okano H,Nakauchi H,Morita Y,Matsumura I,Kudo K,Ito E,Ebihara Y,Tsuji K,Harada Y,Harada H,Okamoto S,Nakajima H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014136.pdf

Reference45 articles.

1. Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004; 10: 299–304.

2. Osato M . Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 2004; 23: 4284–4296.

3. Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T . High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 2004; 103: 2316–2324.

4. Christiansen DH, Andersen MK, Pedersen-Bjergaard J . Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation. Blood 2004; 104: 1474–1481.

5. Harada H, Harada Y, Tanaka H, Kimura A, Inaba T . Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Blood 2003; 101: 673–680.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLI1 is associated with regulation of DNA methylation and megakaryocytic differentiation in FPDMM caused by a RUNX1 transactivation domain mutation;Scientific Reports;2024-06-18

2. GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines;World Journal of Stem Cells;2024-05-26

3. RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks;Blood Advances;2024-05-20

4. DNA methylation analysis using RUNX1-mutated cells reveals association of FLI1 to familial platelet disorder with associated myeloid malignancies caused by a mutation in the transactivation domain of RUNX1;2024-02-20

5. Haploinsufficient Transcription Factors in Myeloid Neoplasms;Annual Review of Pathology: Mechanisms of Disease;2024-01-24